These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 3002663

  • 1. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle.
    Binah O, Sodowick B, Vulliemoz Y, Danilo P, Rosen M.
    Circulation; 1986 Mar; 73(3 Pt 2):III46-51. PubMed ID: 3002663
    [Abstract] [Full Text] [Related]

  • 2. Pharmacology of the bipyridines: amrinone and milrinone.
    Alousi AA, Johnson DC.
    Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
    [Abstract] [Full Text] [Related]

  • 3. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
    Endoh M, Yanagisawa T, Taira N, Blinks JR.
    Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745
    [Abstract] [Full Text] [Related]

  • 4. Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle.
    Sys SU, Goenen MJ, Chalant CH, Brutsaert DL.
    Circulation; 1986 Mar; 73(3 Pt 2):III25-35. PubMed ID: 3002662
    [Abstract] [Full Text] [Related]

  • 5. Phosphodiesterase-inhibiting properties of newer inotropic agents.
    Scholz H, Meyer W.
    Circulation; 1986 Mar; 73(3 Pt 2):III99-108. PubMed ID: 2417748
    [Abstract] [Full Text] [Related]

  • 6. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.
    Endoh M, Yamashita S, Taira N.
    J Pharmacol Exp Ther; 1982 Jun; 221(3):775-83. PubMed ID: 6283063
    [Abstract] [Full Text] [Related]

  • 7. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
    Ahn HS, Eardley D, Watkins R, Prioli N.
    Biochem Pharmacol; 1986 Apr 01; 35(7):1113-21. PubMed ID: 2421728
    [Abstract] [Full Text] [Related]

  • 8. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle.
    Silver PJ, Harris AL, Canniff PC, Lepore RE, Bentley RG, Hamel LT, Evans DB.
    J Cardiovasc Pharmacol; 1989 Apr 01; 13(4):530-40. PubMed ID: 2470989
    [Abstract] [Full Text] [Related]

  • 9. Effects of amrinone and milrinone on calcium influx into the myocardium.
    Sutko JL, Kenyon JL, Reeves JP.
    Circulation; 1986 Mar 01; 73(3 Pt 2):III52-8. PubMed ID: 3002664
    [Abstract] [Full Text] [Related]

  • 10. [Milrinone decreases the positive inotropic response of heart muscle to izadrin].
    Bardamova IB, Afanas'ev SA.
    Eksp Klin Farmakol; 1994 Mar 01; 57(4):29-31. PubMed ID: 7950778
    [Abstract] [Full Text] [Related]

  • 11. Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone.
    Earl CQ, Linden J, Weglicki WB.
    J Cardiovasc Pharmacol; 1986 Mar 01; 8(4):864-72. PubMed ID: 2427830
    [Abstract] [Full Text] [Related]

  • 12. Differential inhibition of cardiac cyclic nucleotide phosphodiesterase isozymes by cardiotonic drugs.
    Harrison SA, Chang ML, Beavo JA.
    Circulation; 1986 Mar 01; 73(3 Pt 2):III109-16. PubMed ID: 3002661
    [Abstract] [Full Text] [Related]

  • 13. Positive inotropic and vasodilating effects of amrinone and milrinone in isolated canine heart.
    Sys SU, Boels PJ, Brutsaert DL.
    J Cardiovasc Pharmacol; 1987 Oct 01; 10(4):445-9. PubMed ID: 2444798
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the cardiotonic effects of milrinone, a new and potent cardiac bipyridine, on isolated tissues from several animal species.
    Alousi AA, Stankus GP, Stuart JC, Walton LH.
    J Cardiovasc Pharmacol; 1983 Oct 01; 5(5):804-11. PubMed ID: 6195468
    [Abstract] [Full Text] [Related]

  • 15. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog.
    Lebedinsky Y, Nordstrom ST, Aschoff SE, Kapples JF, O'Malley GJ, Kosley RW, Fielding S, Hubbard JW.
    J Cardiovasc Pharmacol; 1992 May 01; 19(5):779-89. PubMed ID: 1381777
    [Abstract] [Full Text] [Related]

  • 16. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
    Hayes JS, Bowling N, Boder GB, Kauffman R.
    J Pharmacol Exp Ther; 1984 Jul 01; 230(1):124-32. PubMed ID: 6086873
    [Abstract] [Full Text] [Related]

  • 17. Positive inotropic and chronotropic effects of toborinone and its electrophysiological properties in the isolated hearts of rabbits and guinea-pigs.
    Takase H, Orito K, Mori T, Fujiki H, Sekiguchi K, Tominaga M, Iijima T.
    Arzneimittelforschung; 1996 Jun 01; 46(6):579-86. PubMed ID: 8767347
    [Abstract] [Full Text] [Related]

  • 18. Reduction of 4-epiadriamycin cardiotoxicity by milrinone, a new cardiotonic agent.
    Bossa R, Aresca P, Galatulas I, Ninci M.
    Anticancer Res; 1989 Jun 01; 9(3):605-8. PubMed ID: 2764506
    [Abstract] [Full Text] [Related]

  • 19. Enhanced relaxation and reduced positive inotropic effects of amrinone in ventricular muscle from cats with subacute heart failure. Implications for drug therapy.
    Bassett AL, Gaide MS, Lodge NJ, Cameron JS.
    Adv Myocardiol; 1985 Jun 01; 6():629-36. PubMed ID: 2986264
    [Abstract] [Full Text] [Related]

  • 20. Effect of milrinone on ethanol and halothane induced cardiodepression.
    Neira S, Penna M.
    Acta Physiol Pharmacol Latinoam; 1988 Jun 01; 38(2):193-211. PubMed ID: 2847492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.